T Cell News and Research

Latest T Cell News and Research

Bush adopts the so-called moral high ground and chooses to ignore scientific advice

The American President George W. Bush has used his presidential veto for the first time to block further federal taxpayers money from being used for embryonic stem-cell research.

20 Jul 2006

Latest sequencing targets for NHGRI

The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).

19 Jul 2006

Study indicates heart damage from some cancer drugs worsens over the years

It is well documented that some anti-cancer drugs can damage the heart, but a long-term follow-up of children and young adults who had doxorubicin[1] treatment for bone tumours suggests that the damage gets progressively worse as the years go on.

19 Jul 2006

Researchers find protein associated with brain cell death

Neuroscientists at the Case Western Reserve University School of Medicine have found evidence of which protein in the brain's immune cells triggers a cascade of reactions that produces unregulated free radical production that eventually leads to the neural cell death found in Alzheimer's disease.

19 Jul 2006

Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease

Researchers have unexpectedly shown that sickle cell-associated kidney injury may be reduced by inhibiting the enzyme activity of a protein that commonly confers protection in other diseased states.

19 Jul 2006

Study establishes safety of spinal cord stem cell transplantation

Transplanting human embryonic stem cells does not cause harm and can be used as a therapeutic strategy for the treatment of acute spinal cord injury, according to a recent study by UC Irvine researchers.

19 Jul 2006

Migraine with 'aura' linked to heart attacks

Researchers say that of the 28 million Americans who suffer from migraines, those who experience an "aura" before the start of the pain have an increased risk for heart attack or stroke.

19 Jul 2006

Doctors may be over-diagnosing melanoma in sun-damaged skin

A Mayo Clinic physician and colleagues have defined the normal number of melanocytes that are present in Caucasians' sun-exposed skin.

18 Jul 2006

New role discovered for breast cancer susceptibility gene BRCA1

A recently discovered facet of the breast cancer susceptibility gene BRCA1 reveals a mechanism linking mutation of BRCA1 to formation of large blood vessels needed to support cancer progression.

18 Jul 2006

Researchers isolate rare cancer stem cells that cause leukemia

Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston and their colleagues have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease.

18 Jul 2006

FDA approval for Gemzar for ovarian cancer

Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment of women living with recurrent ovarian cancer.

18 Jul 2006

Secrets of cells revealed

With the advancement of technology we are managing to see ever smaller and smaller pieces of the puzzle that is life.

17 Jul 2006

Crohn's disease - possible genetic cause found

Patients with Crohn's disease of the colon have one copy less than healthy persons of the beta-defensin 2 gene, a gene coding for an important defense molecule of the body.

17 Jul 2006

New genetic clues to dementia with Lewy bodies

Researchers have found that genetic alterations originally identified in people suffering from a rare disease may also be an important risk factor for the second most common form of dementia among the elderly.

17 Jul 2006

Diblock copolymer micellar nanoparticles decorated with annexin-A5 proteins

One of the banes of modern cancer therapy is that clinicians and patients must often wait months before they can tell if a given treatment is working.

17 Jul 2006

Potential new diagnostic test and treatment for lung cancer

University of York spinout company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.

17 Jul 2006

Simple blood test detects lung cancer before it's too late

Researchers in the United States have developed a blood test that is able to correctly predict non-small-cell lung cancer in patients years before any CT scan (computed tomography) can trace it.

17 Jul 2006

New hope for ways to overcome drug resistance in lung cancer

Scientists have suggested it may be possible to reverse drug resistance in lung cancer patients, thereby improving the effectiveness of chemotherapy, according to research published in the EMBO Journal.

13 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

Researchers discover two-way communication and stimulation between blood stem cells and T cells

When a transplant patient suffers complications such as graft rejection or graft-versus-host disease, physicians attempt to stop the body's immune response by targeting a patient's T cells.

13 Jul 2006